York, PANCT06603662Now EnrollingIRB Ready

Osteoarthritis Clinical Trial in York, PA

Access cutting-edge osteoarthritis treatment through this clinical trial at a research site in York. Study-provided care at no cost to qualified participants.

Sponsored by WellSpan Health

Quick Self-Assessment

See if you qualify for this York location

Preparing your pre-screening questions…

Expert Care in York

Access osteoarthritis specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related osteoarthritis treatment provided free

Apply for This York Location

Check if you qualify for this osteoarthritis clinical trial in York, PA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to York

    Convenient for PA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit York site if eligible
  4. 4Begin participation

About This Osteoarthritis Study in York

The purpose of this clinical trial is to compare the analgesic effects (relief of pain) of glucocorticoids (steroids) and pain medication versus pain medication alone in adult patients presenting to the emergency department with joint pain due to osteoarthritis. Steroids are drugs that can reduce inflammation and are used commonly for many different medical conditions. In brief, the central aims of the study are to: 1. Assess the efficacy of adding oral glucocorticoid medications to the standard pain medications used to treat the pain of osteoarthritis. 2. Assess the safety and tolerability of oral glucocorticoid medication for the short-term treatment of osteoarthritis pain. We hypothesize that: 1) The addition of glucocorticoids to standard pain medications will improve reported pain scores at 3 days following the initiation of treatment compared to standard pain medications alone and 2) The use of glucocorticoids will be well tolerated. Participants in the study will be randomized (like flipping a coin) into one of three groups: 1. Study Group 1 (Control) receiving placebo pills (no active ingredient) once a day for 5 days, plus ibuprofen (pain medication) for 5 days. 2. Study Group 2 (Intervention A) who will receive prednisone (steroid) once a day for 5 days, plus ibuprofen (pain medication) for 5 days. 3. Study Group 3 (Intervention B) who will receive one dose of dexamethasone (steroid) followed by placebo pills (no active ingredient) once a day for 4 days, plus ibuprofen (pain medication) for 5 days. In all groups, acetaminophen (a different pain medication) can be taken as needed for pain that is not controlled with ibuprofen. Participants will: * Receive follow up phone calls at 1, 3, 7 and 14 days. * Report pain scores related to joint pain. * Report the number of pills taken of the various medications used in the study. * Report any adverse events incurred during the follow up period.

Sponsor: WellSpan Health

Who Can Participate

Inclusion Criteria

Age ≥18 years
Acute monoarticular arthritic joint pain affecting native knee, hip, or shoulder presumed to be related to osteoarthritis
Acute pain above baseline starting less than 72 hour prior to ED visit
Planned discharge from the ED
History of osteoarthritis of the affected joint based on radiography performed at index visit or prior available imaging

Exclusion Criteria

Trauma to the affected joint within 30 days
Injection of affected joint within 60 days
Prior arthroplasty of the affected joint
History of coronary artery disease, severe gastrointestinal bleeding, gastric/peptic ulcer disease, chronic kidney disease with GFR less than 30, or platelet disorders (including von Willebrand disease, hemophilia, severe thrombocytopenia with platelets less than 50 k/mcL)
Joint pain suspected to be related to rheumatoid arthritis, gout, septic arthritis, or other non-osteoarthritis autoimmune/inflammatory/infectious arthritis
Chronic/baseline use of glucocorticoids (greater than 5 mg daily prednisone or equivalent within previous 7 days) or NSAIDs (daily use for more than 2 days prior to presentation)
Daily prescription opioid use or active opioid use disorder
Illicit drug use
Known allergy/intolerance to ibuprofen/NSAIDs, prednisone, dexamethasone, or other medication precluding ability to participate in one or more study arms
Other contraindications to ibuprofen/NSAIDs or glucocorticoids
Planned hospitalization from the ED
Incarceration
Inability to provide informed consent
Other conditions that would preclude compliance with the study protocol and medication dosing

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in York?

Yes, this clinical trial (NCT06603662) has an active research site in York, PA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Osteoarthritis Treatment Options in York, PA

If you're searching for osteoarthritis treatment options in York, PA, this clinical trial (NCT06603662) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our York research site is actively enrolling participants for this clinical trial. You'll receive care from experienced osteoarthritis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all osteoarthritis clinical trials near you to find additional studies recruiting in your area.

More Osteoarthritis Trials in York, PA

See all osteoarthritis clinical trials recruiting in York — not just this study.

Browse Osteoarthritis Trials in York

Browse More Trials by Condition

Ready to Join in York?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · York, PA